Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humansA Santos, S Zanetta, T Cresteil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinomaJ Taïeb, E Mitry, V Boige, et al.
British Journal of Cancer|October 9, 2008
Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancerT Conroy, F Viret, E François, et al.
AJR. American Journal of Roentgenology|November 25, 2000
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 yearT de Baere, D Elias, C Dromain, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosisC Caramella, E Pottier, I Borget, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 19, 2013
Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancersD Elias, I Borget, M Farron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastomaE Raymond, M Fabbro, V Boige, et al.
BMC Cancer|February 26, 2024
Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort studyA Gueiderikh, A Tarabay, M Abdelouahab, et al.
Critical Reviews in Oncology/Hematology|June 18, 2011
Disseminated and circulating tumor cells in gastrointestinal oncologyF C Bidard, F R Ferrand, F Huguet, et al.
Pageof 8